{"id":"https://openalex.org/W2391699561","doi":null,"title":"Reversal effect of FG020318 on multidrug resistance in retinoblastoma cell line SO-Rb50","display_name":"Reversal effect of FG020318 on multidrug resistance in retinoblastoma cell line SO-Rb50","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2391699561","mag":"2391699561"},"language":"en","primary_location":{"id":"mag:2391699561","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZBLS200710035.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2765062696","display_name":"Zhongguo bingli shengli zazhi","issn_l":"1000-4718","issn":["1000-4718"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1"],"host_organization":"https://openalex.org/P4320800525","host_organization_name":"Chinese Medical Association","host_organization_lineage":["https://openalex.org/P4320800525"],"host_organization_lineage_names":["Chinese Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo bingli shengli zazhi","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026570937","display_name":"Danping Huang","orcid":"https://orcid.org/0000-0003-4252-3611","observed_orcids":["https://orcid.org/0000-0003-4252-3611"]},"institutions":[{"id":"https://openalex.org/I157773358","display_name":"Sun Yat-sen University","ror":"https://ror.org/0064kty71","country_code":"CN","type":"education","lineage":["https://openalex.org/I157773358"]},{"id":"https://openalex.org/I4391768270","display_name":"State Key Laboratory of Ophthalmology","ror":"https://ror.org/003mfbe21","country_code":"CN","type":"facility","lineage":["https://openalex.org/I157773358","https://openalex.org/I4391768270"]},{"id":"https://openalex.org/I4401726874","display_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","ror":"https://ror.org/02z2yec16","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I157773358","https://openalex.org/I4401726874"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Huang Dan-ping","raw_affiliation_strings":["State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China"],"raw_orcid":"https://orcid.org/0000-0003-4252-3611","affiliations":[{"raw_affiliation_string":"State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China","institution_ids":["https://openalex.org/I157773358","https://openalex.org/I4391768270","https://openalex.org/I4401726874"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5026570937"],"corresponding_institution_ids":["https://openalex.org/I157773358","https://openalex.org/I4391768270","https://openalex.org/I4401726874"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36862017,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistance-reversal","display_name":"multidrug resistance reversal","score":0.9760000109672546},{"id":"https://openalex.org/keywords/retinoblastoma","display_name":"retinoblastoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/vincristine-resistance","display_name":"vincristine resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9520000219345093},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9269999861717224},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.5379999876022339},{"id":"https://openalex.org/keywords/rhodamine-123-accumulation","display_name":"rhodamine 123 accumulation","score":0.8069999814033508},{"id":"https://openalex.org/keywords/mdr-modulators","display_name":"MDR modulators","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.8515228629112244},{"id":"https://openalex.org/C2778589691","wikidata":"https://www.wikidata.org/wiki/Q3429577","display_name":"Rhodamine 123","level":4,"score":0.8256179094314575},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.7287752628326416},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6366055011749268},{"id":"https://openalex.org/C2776577112","wikidata":"https://www.wikidata.org/wiki/Q500695","display_name":"Retinoblastoma","level":3,"score":0.6019141674041748},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.5319153666496277},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5206350684165955},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5192853808403015},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4845680296421051},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.46204420924186707},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4473617374897003},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3912162780761719},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38542842864990234},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3683759570121765},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34160783886909485},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23776429891586304},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18056917190551758},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12657538056373596},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.1125434935092926},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.11182332038879395},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.054936885833740234},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2391699561","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZBLS200710035.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2765062696","display_name":"Zhongguo bingli shengli zazhi","issn_l":"1000-4718","issn":["1000-4718"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["jufo-1"],"host_organization":"https://openalex.org/P4320800525","host_organization_name":"Chinese Medical Association","host_organization_lineage":["https://openalex.org/P4320800525"],"host_organization_lineage_names":["Chinese Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo bingli shengli zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2146790338","https://openalex.org/W2359733981","https://openalex.org/W2412886865","https://openalex.org/W2025620369","https://openalex.org/W1980169150","https://openalex.org/W2324158402","https://openalex.org/W3148084113","https://openalex.org/W2802120160","https://openalex.org/W2112929496","https://openalex.org/W2360604053"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"investigate":[2],"the":[3,59,80,92],"multidrug":[4],"resistance(MDR),reversal":[5],"activity":[6],"of":[7,21,40,61,98],"2-[4-(2-pyridin-2-yl-vinyl)":[8],"henyl]-4,5-bis-(4-N,N-diethylaminophenyl)-1(H)-imidazole(FG020318)":[9],"in":[10,24,83,96,109],"a":[11,84,113],"retinoblastoma":[12],"subline":[13],"SO-Rb50/VCR,which":[14,31],"is":[15],"resistant":[16,33,43],"to":[17,29,34,117],"vincristine.METHODS:":[18],"The":[19,38],"procedure":[20],"stepwise":[22],"increase":[23],"drug":[25,42,116],"concentrations":[26],"was":[27,32,63,88],"used":[28],"obtain":[30],"200":[35],"\u03bcg/L":[36],"vincristine.":[37],"chemosensitivity":[39],"this":[41],"cell":[44],"line":[45],"with":[46,70],"and":[47,58,78],"without":[48],"FG020318":[49,105],"or":[50],"cyclosporine":[51],"A(CSA)":[52],"were":[53],"detected":[54,69],"by":[55,65],"MTT":[56],"assay":[57],"function":[60],"p-glycoprotein(P-gp)":[62],"examined":[64],"rhodamine":[66,81],"123":[67],"accumulation":[68,82],"flow":[71],"cytometry(FCM).RESULTS:":[72],"FG020318(2.5":[73],"\u03bcmol/L)":[74],"significantly":[75],"reduced":[76],"IC50":[77],"increased":[79],"concentration-dependent":[85],"manner.":[86],"It":[87],"much":[89],"stronger":[90],"than":[91],"positive":[93],"control":[94],"CSA":[95],"reversal":[97],"MDR.CONCLUSION:":[99],"A":[100],"new":[101,115],"tumor":[102],"MDR":[103,108],"modulator":[104],"partly":[106],"reverses":[107],"SO-Rb50/VCR.It":[110],"may":[111],"be":[112],"promising":[114],"tackling":[118],"MDR.":[119]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}